Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin by unknown
MOUSE H-2k-RESTRICTED CYTOTOXIC T CELLS
RECOGNIZE ANTIGENIC DETERMINANTS IN BOTH THE
HAI AND HA2 SUBUNITS OF THE INFLUENZA A/PR/8/34
HEMAGGLUTININ
BY KEITH G. GOULD, HILARY SCOTNEY, ALAIN R. M. TOWNSEND,*
JUDY BASTIN,* AND GEORGE G. BROWNLEE
From the Sir William Dunn School ofPathology, University ofOxford, Oxford OX13RE, and
the *Nuffield Department ofMedicine, John Radclie Hospital,
Oxford OX3 9DU United Kingdom
CTL specifically recognize and lyse virus-infected target cells generally in
conjunction with self class I MHC molecules (1). Infection by influenza A viruses
produces a vigorous CTL response in both mice and humans (2), and this may
be important in limiting the spread of viral infection and in viral clearance (3,
4). Influenza A virus hemagglutinin (HA)' is known to serve as a target antigen
for influenza-specific murine CTL (5-7), although the nucleoprotein, rather
than the HA, appears to be the major influenza protein recognized by CTL (7,
8).
The HA molecule consists of a heavy chain subunit (HAI) of ^-330 amino acid
residues and a light chain subunit (HA2) of -220 amino acid residues held
together by a single disulfide bond (9). The antigenicity of the HA for B
lymphocytes has been well studied, and a number of dominant antigenic regions
have been localized within the HAI subunit (10, 11). In contrast, much less is
known about the sites within the HA molecule recognized by CTL.
Recently, recombinant vaccinia viruses expressing individual influenza genes
have been shown to prime and stimulate specific CTL responses in mice (8, 12,
13). Cells infected with recombinant vaccinia viruses can also serve as targets for
MHC-restricted CTL specific for the product of the inserted gene (8, 12, 13).
We and others, using vaccinia viruses expressing influenza A/PR/8/34 or
A/JAP/305/57 HA, have confirmed that HA is a target antigen for polyclonal
CTL (5, 12, 14), and have also shown that there is very little crossreaction of
CTL between different HA subtypes (5, 14). This was confirmed in an analysis
of the specificity of 10 HA-specific CTL clones (15). Minimal crossreaction of
CTL occurs between HAs of H1 and H3 subtypes, as expected from the relative
amino acid homologies between different HA subtypes (16, 17). We have taken
advantage of this specificity to test whether determinants in the A/PR/8/34 HA
for H-2k-restricted polyclonal CTL occur in the HAI, HA2, or in both subunits.
We chose to construct genes coding for intact HA molecules in which the HAI
subunits of A/PR/8/34 (HI subtype) and A/NT/60/68 (H3 subtype) were
' Abbreviation used in this paper:
￿
HA, hemagglutinin.
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exchanged to give two chimeric HA molecules. These chimeric genes were used
to construct recombinant vaccinia viruses expressing HA polypeptides. In one
chimera the HA1 subunit is of H1 subtype and the HA2 subunit is of H3 subtype,
and in the second chimera the HA1 subunit is of H3 subtype and the HA2
subunit is of H 1 subtype. Although these molecules do not exist naturally, they
might be expected to form structures similar to naturally occurring HA mole-
cules, and to behave in a similar manner in the infected cell. We have used the
recombinant vaccinia viruses expressing chimeric HAs to prime mice and to test
the specificity of any CTL response. In addition, cells infected with the recom-
binant vaccinia viruses have been tested as targets for HA-specific CTL .
Materials and Methods
Recombinant Vaccinia Viruses Containing HA Gene Chimeras.
￿
A full-length cDNA clone
of the HA ofhuman influenza A/NT/60/68 (H3 subtype) was constructed using the same
method (7) as previously used for the HA of influenza A/PR/8/34 (HI subtype, Mount
Sinai strain). A Stu I restriction enzyme site was introduced into the cDNA clone of the
A/PR/8/34 HA at the junction between the HA1 and HA2 subunits (17) using a 22-
nucleotide-long mismatch oligonucleotide (18) to direct (19) the synthesis of the required
mutation in the HA clone, inserted in M13mp8. A Stu I site exists naturally in the
equivalent position in the A/NT/60/68 HA gene (20). The chimeric genes KG I I and
KG 12 were constructed by ligating the required restriction fragments, isolated from
agarose gels, with Hind III-Bam HI cut pKG5 plasmid (pKG5 [Gould, K., unpublished
data] is a derivative of pSVtkneo (7), containing extra cloning sites) . In the case of the
cDNA clone derived from A/NT/60/68, a partial Hind III digest was required to isolate
the region encoding the entire HA I subunit because of the presence of an internal Hind
III site. Similarly, a partial Bam HI digest was required for the isolation of the region
encoding the HA2 subunit. Recombinant vaccinia viruses expressing the two chimeric
HAs, the H1 subtype HA, and the H3 subtype HA were made by standard methods (21,
22) . The viruses were designated KG11-VAC, KG12-VAC, H1-VAC, and H3-VAC,
respectively (Fig. 2). Plasmid pGS62 (23) was used as the insertion vector, except for the
construction of H1-VAC. In that case a new vector, pKG18 (Gould, K., unpublished
data), a derivative of pGS62 using the same vaccinia promoter for expression but with
extra cloning sites, was used.
Immunoprecipitation.
￿
Confluent 25-cmz flasks of CV-1 cells were infected with vaccinia
viruses at 30 PFU/cell . After 1 h at 37°C the innoculum was removed and replaced by
methionine-free DME medium with 5% FCS. After a further 2 h at 37°C, 100 pCi of
["S]methionine was added to each flask. 1 .5 h later cells were harvested, washed once
with PBS, and treated as described previously (7, 22).
Cytotoxic TCell Cultures In Vitro and CTL Assay.
￿
3-6-mo-old female CBA mice (H-2k)
were primed intravenously by injecting 107 PFU of recombinant vaccinia virus in 0.1 ml
of PBS into the tail vein (12). 2 wk later their spleens were removed and the spleen cells
were stimulated in vitro, as described previously (7). Briefly, 1 .2 x 107 spleen cells were
mixed with 2 x 10' syngeneic, 2,000 rad irradiated, A/PR/8/34 virus-infected feeder
spleen cells in 15 ml of complete medium (RPMI 1640, 10% FCS, 5 x 10-5 M 2-ME) .
Cultures were harvested after 5 d at 37°C for testing in a standard 6-h 5'Cr-release assay,
with modifications for the use of adherent L929 target cells (H-2"), as described (7). 2 x
10' target cells were infected with 0 .2 ml of infectious allantoic fluid or 2 x 107 PFU
vaccinia virus and labeled with 125 ACi of "Cr for 90 min at 37 °C. Percentage of specific
chromium release was calculated as follows: Percent release = 100 x [(release by CTL) -
(medium release)]/[(2 .5% Triton release) - (medium release)].
Each point was measured in duplicate against quadruplicate controls.327 328 329 1
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FIGURE 1 .
￿
Strategy for the construction of a Stu I restriction enzyme site at the junction
between the HAI and HA2 subunits of the A/PR/8/34 HA gene .
FIGURE 2 .
￿
Thedesign and construction of chimericHA genes . Theappropriate gel-purified
restriction fragments were ligated together as shown, together with Barn HI + Hind III
double-cut pKG5 plasmid vector, as described in Materials and Methods . The chimeras were
designated KG I 1 and KG12, as indicated .
Design and Construction of Chimeric HA Genes.
￿
A naturally occurring and
unique Stu I restriction enzyme recognition site (Fig . 1) is present at the precise
junction of theHA1 and HA2 subunits in thecDNA clone derived from theHA
of influenza A/NT/60/68 (20), and allowed us to design and construct artificial
HA1-HA2 chimeras between influenza strains of H1 and H3 subtype. For the
design (see below) to work, we first had to mutate a T -> C in the HA clone
derived from influenza A/PR/8/34 to generate a Stu I site, using site-specific
mutagenesis (see Materials and Methods) .
The design of the chimeras KG I I and KG 12 is shown in Fig . 2 and involves
ligation of the relevant restriction fragments, isolated from the wild-type cDNA
clone of the A/NT/60/68 HA and from the mutant HA clone of A/PR/8/34,
with the plasmid pKG5 (see Materials and Methods) . Recombinant vaccinia
viruses containing these chimeric HAs as well as the wild-type HAs were con-696 CYTOTOXIC T CELL RECOGNITION OF INFLUENZA HEMAGGLUTININ
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FIGURE 3 .
￿
Immunoprecipitation of HA polypeptides from cells in-
fected with recombinant vaccinia viruses . Cells were infected with
vaccinia viruses and labeled with [sSSlmethionine as described in Ma-
terials and Methods . Polyclonal antiserum R401 (H1 subtype) was used
for immunoprecipitation from H1-VAC- and KG11-VAC-infected
cells, and antiserum X31 (H3 subtype) for immunoprecipitation from
KG12-VAC-and H3-VAC-infected cells . Proteins were resolved on a
10% SDSpolyacrylamide gel, the gel was treated with sodium salicylate,
dried down, and autoradiographed for 49 h. The arrow indicates the
position of H1 HA immunoprecipitated from influenza A/PR/8/34-
infected cells . Immunoprecipitation of cells infected with nonrecom-
binant vaccinia virus strain WR gave no visible bands (not shown) .
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FIGURE 4 .
￿
Specificity of CTL generated by priming CBA mice with recombinant vaccinia
viruses . Mice were primed as described in Materials and Methods, the resulting splenocytes
were stimulated in vitro with influenza A/PR/8/34 (H1 subtype), and were tested in a
chromium-release assay using L929 target cells infected with (O) influenza A/PR/8/34 (HI
subtype); (0) influenza A/NT/60/68 (H3 subtype) ; (O) uninfected . Spontaneous release from
labeled target cells in medium alone was 24-28% that released by Triton X-100 .
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FIGURE 5.
￿
Specificity of CTL generated by priming CBA mice with H1-VAC. Mice were
primed as described in Materials and Methods, the resulting splenocytes were stimulated in
vitro with influenza A/PR/8/34 (H1 subtype), and were tested in a chromium-release assay.
L929 target cells were (O) infected with the indicated recombinant vaccinia virus at 10
PFU/cell ; (p) uninfected. Spontaneous release from labeled target cells in medium alone was
16-24% that released by Triton X-100.
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structed (see Materials and Methods) and are referred to as KG I 1-VAC, KG 12-
VAC, H1-VAC, and H3-VAC .
Expression of HA Polypeptides by Recombinant Vaccinia Viruses.
Immunoprecipitation of polypeptides from cells infected with the four recombi-
nant vaccinia viruses showed that HA molecules of the expected molecular
weights are synthesized in good yield (Fig. 3). The two chimeric HAs are
recognized by antisera specific for the subtype of the HA I subunit. The slight
difference in mobility of the intact HAs in the four tracks is probably related to
differing extents of glycosylation, although all the HAs have the same number
of potential glycosylation sites. The minor low molecular weight bands in the
KG 1 1 and KG 12 tracks presumably reflect HA breakdown products, and their
absence in the H1 and H3 tracks indicates decreased stability of the chimeric
HAs. Expression of HA polypeptides on the cell surface was confirmed by FACS
profiles of recombinant virus-infected cells stained with HA-specific mAbs (data
not shown) .
Both Subunits of the HA Molecule Prime Mice for an HA Subtype-specific CTL
Response. As expected, priming mice (see Materials and Methods) with control
H1-VAC generates H1 subtype-specific polyclonal CTL that do not lyse H3
influenza virus-infected target cells (Fig. 4). Priming with control H3-VAC and
stimulating with H1 influenza virus generates barely detectable influenza-specific
CTL. In contrast, priming with vaccinia virusesexpressing the two chimeric HAs698 CYTOTOXIC T CELL RECOGNITION OF INFLUENZA HEMAGGLUTININ
(KGI I -VAC and KG12-VAC) gives a strong H1-specific CTL response in both
cases (Fig. 4). These results clearly show that both the HAI and HA2 subunits
of the A/PR/8/34 HA molecule contain determinants for generating CTL.
Both Subunits of the HA Molecule Are Targets for HA-specific Polyclonal
CTL. Cells infected with each of the four recombinant vaccinia viruses were
tested as targets for CTL generated by priming mice with H1-VAC (Fig. 5). As
expected from previous results (7, 14), control H1-VAC CTL recognize H1-
VAC-infected cells but only show a small amount of crossreaction with control
H3-VAC-infected cells. Here we observethatboth chimeric HA molecules (KGI 1
and KG12 targets) are recognized efficiently (Fig. 5). In three different experi-
ments, including that shown in Fig. 5, lysis oftargets expressing the HA2 subunit
of HI subtype (i.e., KG12-VAC) was higher than lysis oftargets expressing the
HA2 subunit ofH3 subtype (i.e., KG11-VAC).
Discussion
In this report we show that both subunits ofthe HA of influenza A/PR/8/34
(HI subtype) contain an antigenic determinant or determinants for CTL in CBA
(H-2k) mice. This is in agreement with other work (15) that suggested that CTL
derived from H-2' mice recognize up to four distinct antigenic sites within the
HA molecule of A/JAP/305/57 (H2 subtype). Recently, it has been shown (24)
thatthe epitopes ofinfluenza nucleoprotein recognized by class I MHC-restricted
CTL can be defined with short synthetic peptides. These and other experiments
(25, 26) suggest that class I-restricted recognition by CTL might involve pro-
cessed antigenic fragments, as is the case for class II-restricted recognition of
antigen by helper Tcells (27).
We have shown previously (14) that HA lackingan NH2-terminal signal peptide
is efficiently recognized by CTL. This HA molecule is not transported to the
cell surface but is rapidly degraded within the cytosol (14), and thus it is unlikely
that the sites recognized by CTL within the HA are dependent on the correct
conformation ofthe molecule. Studies with cyanogen bromide fragments derived
from the HA of influenza virus A/JAP/305/57 suggested that recognition by
CTL could be localized to subpolypeptide regions (28). In an extension ofthese
experiments, two peptides, HA I (amino acids 181-204) and HA2 (amino acids
103-123), were found to generate murine secondary antiinfluenza CTL in vitro
(29, 30). Different work using engineered proteins produced in Escherichia coli
suggested that the HA2 subunit of influenza virus A/PR/8/34 could stimulate
the production of secondary CTL in vitro (31, 32). However, this was only true
if the HA2 polypeptide chain was fused to 81 amino acids ofanother influenza
protein, the nonstructural protein NS1 . Other workers failed to show the
induction of a secondary CTL response using purified HA2 subunit derived
from influenza virus A/FPV/Rostock/34 (H7 subtype) (33). Our results clearly
show that for CBA mice there is an immunogenic site or sites for CTL within
each subunit of the H1 subtype HA molecule.
As it now seems that recognition by both CTL and helper T cells involves
antigen processing (24, 26), it is interesting to consider whether both types ofT
cell recognize the same sites within the HA molecule . A recent study (34) showed
that there are determinants for proliferative T cells on both the HA I and HA2subunits of H2 and H3 subtype HAs (34). However, the three recognition sites
for helper T cells within the A/PR/8/34 HA (H 1 subtype) that have been defined
in detail so far are all in the HA1 subunit (35). Clearly, further work using CTL
clones is necessary to define precisely the sites within the A/PR/8/34 HA
molecule that are recognized. Recently, it has been shown (36) that T cell
antigenic sites tend to be amphipathic structures. This allows predictions to be
made about the location of T cell recognition sites within proteins. The chemical
synthesis of peptides corresponding to these regions and their use in chromium-
release assays should allow precise identification of CTL recognition sites within
the HA molecule.
Summary
We have constructed two chimeric influenza hemagglutinin (HA) genes in
which the HA I and HA2 subunits of the HA molecule have been interchanged
between influenza A/PR/8/34 (HI subtype) and A/NT/60/68 (H3 subtype).
These genes were used to construct recombinant vaccinia viruses that expressed
intact chimeric HA. These recombinant viruses were used to test whether murine
CTL recognize antigenic determinants in either the HA 1, HA2, or both subunits.
We found that both subunits of the HA molecule contain determinants for CTL .
This implies that CTL have, at least in part, separate antigenic determinants
from B lymphocytes, which recognize mainly epitopes within the HA I subunit.
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